| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 16206346 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 666 journal articles in the PubMed database | Email to a friend | | |
| Maksymowych WP, Poole AR, Hiebert L, et al.
Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. [Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial]
J Rheumatol 2005 Oct; 32(10):1911-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yang CH, Huang F, Deng XH, et al.
[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis] [English Abstract, Journal Article]
Zhonghua Yi Xue Za Zhi 2006 Sep 19; 86(35):2451-4.
Abstract | Full Citation | Find Related Articles | | Kim TH, Stone M, Payne U, et al.
Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response. [Journal Article]
Arthritis Rheum 2005 Mar; 52(3):885-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Woo JH, Lee HJ, Sung IH, et al.
Changes of Clinical Response and Bone Biochemical Markers in Patients with Ankylosing Spondylitis Taking Etanercept. [JOURNAL ARTICLE]
J Rheumatol 2007 Jun 15.
Abstract | Full Citation | | Maksymowych WP, Jhangri GS, Lambert RG, et al.
Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety. [Clinical Trial, Journal Article]
J Rheumatol 2002 May; 29(5):959-65.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | McLeod C, Bagust A, Boland A, et al.
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. [Journal Article]
Health Technol Assess 2007 Aug; 11(28):1-158.
Abstract | Full Citation | | Fraser A, Fearon U, Billinghurst RC, et al.
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. [Journal Article]
Arthritis Rheum 2003 Nov; 48(11):3085-95.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Maksymowych WP, Landewé R, Conner-Spady B, et al.
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. [Journal Article]
Arthritis Rheum 2007 Jun; 56(6):1846-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Catrina AI, Lampa J, Ernestam S, et al.
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. [Clinical Trial, Journal Article]
Rheumatology (Oxford) 2002 May; 41(5):484-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
